| Treatment of Fabry’s disease with the pharmacologic chaperone migalastat DP Germain, DA Hughes, K Nicholls, DG Bichet, R Giugliani, WR Wilcox, ... New england journal of medicine 375 (6), 545-555, 2016 | 649 | 2016 |
| Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping DM Sado, SK White, SK Piechnik, SM Banypersad, T Treibel, G Captur, ... Circulation: Cardiovascular Imaging 6 (3), 392-398, 2013 | 581 | 2013 |
| Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study DA Hughes, K Nicholls, SP Shankar, G Sunder-Plassmann, D Koeller, ... Journal of medical genetics 54 (4), 288-296, 2017 | 478 | 2017 |
| Effects of enzyme replacement therapy on the cardiomyopathy of Anderson–Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa DA Hughes, PM Elliott, J Shah, J Zuckerman, G Coghlan, J Brookes, ... Heart 94 (2), 153-158, 2008 | 415 | 2008 |
| Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor I Fraser, D Hughes, S Gordon Nature 364 (6435), 343-346, 1993 | 411 | 1993 |
| Characterization of classical and nonclassical Fabry disease: a multicenter study M Arends, C Wanner, D Hughes, A Mehta, D Oder, OT Watkinson, ... Journal of the American Society of Nephrology 28 (5), 1631-1641, 2017 | 399 | 2017 |
| Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease DM Sado, AS Flett, SM Banypersad, SK White, V Maestrini, G Quarta, ... Heart 98 (19), 1436-1441, 2012 | 396 | 2012 |
| Natural history of Fabry disease in females in the Fabry Outcome Survey PB Deegan, AF Baehner, MAB Romero, DA Hughes, C Kampmann, ... Journal of medical genetics 43 (4), 347-352, 2006 | 393 | 2006 |
| Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document M Biegstraaten, R Arngrímsson, F Barbey, L Boks, F Cecchi, PB Deegan, ... Orphanet journal of rare diseases 10, 1-10, 2015 | 389 | 2015 |
| Macrophage recruitment during limb development and wound healing in the embryonic and foetal mouse J Hopkinson-Woolley, D Hughes, S Gordon, P Martin Journal of cell science 107 (5), 1159-1167, 1994 | 360 | 1994 |
| The macrophage scavenger receptor type A is expressed by activated macrophages and protects the host against lethal endotoxic shock R Haworth, N Platt, S Keshav, D Hughes, E Darley, H Suzuki, Y Kurihara, ... The Journal of experimental medicine 186 (9), 1431-1439, 1997 | 346 | 1997 |
| Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer … AG Lai, L Pasea, A Banerjee, G Hall, S Denaxas, WH Chang, M Katsoulis, ... BMJ open 10 (11), e043828, 2020 | 309 | 2020 |
| Prevalence and clinical significance of cardiac arrhythmia in Anderson-Fabry disease JS Shah, DA Hughes, B Sachdev, M Tome, D Ward, P Lee, AB Mehta, ... The American journal of cardiology 96 (6), 842-846, 2005 | 290 | 2005 |
| Identification of macrophages and dendritic cells in the osteopetrotic (op/op) mouse MD Witmer-Pack, DA Hughes, G Schuler, L Lawson, A McWilliam, K Inaba, ... Journal of cell science 104 (4), 1021-1029, 1993 | 271 | 1993 |
| The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat ER Benjamin, MC Della Valle, X Wu, E Katz, F Pruthi, S Bond, B Bronfin, ... Genetics in Medicine 19 (4), 430-438, 2017 | 269 | 2017 |
| Murine macrophage scavenger receptor: in vivo expression and function as receptor for macrophage adhesion in lymphoid and non‐lymphoid organs DA Hughes, IP Fraser, S Gordon European journal of immunology 25 (2), 466-473, 1995 | 261 | 1995 |
| Multiple myeloma: causes and consequences of delay in diagnosis CC Kariyawasan, DA Hughes, MM Jayatillake, AB Mehta QJM: An International Journal of Medicine 100 (10), 635-640, 2007 | 255 | 2007 |
| Gaucher disease GM Pastores, DA Hughes | 250 | 2018 |
| Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation–positive cohort M Beavan, A McNeill, C Proukakis, DA Hughes, A Mehta, AHV Schapira JAMA neurology 72 (2), 201-208, 2015 | 241 | 2015 |
| Prevalence of Anderson–Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson–Fabry Disease Survey P Elliott, R Baker, F Pasquale, G Quarta, H Ebrahim, AB Mehta, ... Heart 97 (23), 1957-1960, 2011 | 239 | 2011 |
